Reference Publications
Whitehall Report 2022
October 25, 2022
As the 2022 calendar year comes to a close, all eyes will be on our new government and the stance they take to support, or revise, key agenda items in the health and social care space across England. In an inflationary environment, they will no doubt feel pressure to ease the burden without making longer-term commitments. Historically, governments have been reluctant to raise tariffs and reimbursement rates for perceivably transient inflationary pressures, unless they become embedded, and in the short term may resort to one-off cash injections to bail out struggling providers rather than commit to long-term reimbursement/tariff uplift. We anticipate providers, payers and investors alike will be monitoring the situation closely across the coming months as continued CPI and wage inflation may force the issue to be addressed in 2023.
Our annual Whitehall Report acts as an important reference document to decode the complexity of health and care in England. We hope our insights into key and ongoing developments affecting the regulatory, funding, and policy levers impacting the health and social care markets in England help support decision-making for investors in the sector. We hope you enjoy our Whitehall Report and look forward to further discussing the topics that we have covered.
Whitehall Report 2021
December 8, 2021
The Marwood Group publishes its Whitehall Report 2021 against a backdrop that sadly remains dominated by Covid-19. However, with 80% of over 16’s having received both vaccination doses and a relaxation of the lockdown restrictions across the UK, there is increasing optimism that the worst of the pandemic may be behind us. Challenges of course remain – and the impact will be felt for years to come – but for the first time in nearly 18 months, health leaders can move from operational survival to strategic planning.
Our report covers the key policy, funding and regulatory developments from August 2020 through to August 2021. Readers will note that the year has been a mixture of the government forging ahead on select policy issues, whilst attempting to manage the pandemic. As a result, a number of lower priority, or potentially politically unpopular, decisions have found themselves delayed. Even as we go to press, the Prime Minister is attempting to steer crucial funding decisions for social care past a sceptical Conservative backbench, whilst attempting to negate any politicisation of the issue by Labour.
Whitehall Report 2020
September 16, 2020
The development of the Covid-19 pandemic since January has led to widespread changes across all sectors. Its immediate impact on health, social care and the life sciences has led to unprecedented short-term funding injections, with policy and regulatory development proceeding at a pace rarely seen. It is understandable that investors and operators may have found it difficult to keep informed about important changes impacting on health, social care, and the life sciences.
The Whitehall Report 2020 remains focused on supporting investors and corporations navigate the complex health and care landscape in England. It provides insights into the key developments affecting the regulatory, reimbursement, and policy levers impacting on the health, social care and life sciences markets.
European Fact Files 2020
May 6, 2020
Despite sharing common features, health and care systems across Europe are unique, both in terms of their financing and structure. This in turn drives how the commercial landscape also evolves which can vary significantly by country and by region. Europe therefore cannot be viewed as a homogeneous entity, with a one-size-fits-all solution. Instead investors and operators alike must get to grips with the specific challenges within individual territories.
Marwood Group produces an annual European Fact Files to support investors and operators in their understanding of national contexts, and enable the development of informed strategies and sound investment choices. Our Fact Files decode the complexities of navigating multiple health and social care systems in Europe by providing a clear snapshot into key countries.
Whitehall Report 2019
September 10, 2019
With media attention fixed on Brexit, parliamentary intrigue and an imminent general election, it is understandable that investors and operators may have found it difficult to keep informed about important changes impacting on health, social care, and the life sciences. However, with attention focused elsewhere, policy makers have been quietly pushing forward with significant reforms that could impact on investment decisions.
Marwood Group has produced the Whitehall Report 2019 to support investors and corporations navigate the complex health and care landscape in England. It provides insights into the key developments affecting the regulatory, reimbursement, and policy levers impacting on the health, social care and life sciences markets.
We reflect on how the NHS Long Term Plan has given system transformation plans new impetus and set broad health objectives for the next ten years. We examine how the multi-year funding settlement will support these priorities, the role that innovative technology and pharmaceuticals will play in the future of care, and the continuing pressure facing social care services.
European Fact Files 2019
April 8, 2019
Despite sharing common features, health and care systems in Europe are unique, both in terms of their financing and structure. Their current form has evolved over time driven by politics, cultural expectations and economic conditions. Europe cannot be viewed as a homogeneous entity, with a one-size-fits-all solution. Instead investors must get to grips with the specific challenges within individual territories.
Marwood Group produces an annual European Fact Files to support investors and companies in their understanding of national contexts, and enable the development of informed strategies and sound investment choices. Our Fact Files decode the complexities of navigating multiple health and social care systems in Europe by providing a clear snapshot into key countries.
This year’s edition covers 16 different healthcare systems, alongside an overview of the key developments in the EU’s regulation of medical devices and pharmaceutical products.
Whitehall Report 2018
September 17, 2018
Marwood Group has produced the Whitehall Report 2018 to support investors and corporations navigate the complex health and care landscape in England. It provides insights into the key developments affecting the regulatory, reimbursement, and policy levers impacting on the health, social care and life sciences markets.